Welcome to CURA

Let's configure your regulatory intelligence workspace.

Are you an HCP or a manufacturer?

Select your primary role in the healthcare ecosystem.

Login
RWE

Real-World Evidence (RWE) Analytics

EHR, claims, registry, and patient-derived real-world data

Real-World Evidence (RWE) analytics transforms observational healthcare data into actionable insights for drug development, regulatory submissions, and post-market surveillance. Our platform integrates EHR records, insurance claims, disease registries, and patient-reported outcomes to support evidence generation across the full product lifecycle.

EHR / EMR Analytics

Structured clinical data from 200M+ patient records

Treatment patterns, comorbidity analysis, lab trends

Claims-Based Studies

Commercial & Medicare claims at 95% coverage

Utilization, cost, adherence, market share

Disease Registries

SMA, CF, Hemophilia, rare disease & oncology

Natural history, long-term outcomes, PROs

RWE Use Cases

  • -FDA Real-World Evidence Program submissions (21st Century Cures Act)
  • -Post-authorization safety studies (PASS) and REMS compliance data
  • -Healthcare utilization & cost-effectiveness analysis for HTA submissions
  • -Label expansion feasibility & supplemental indication data packages
  • -Patient journey mapping from diagnosis through treatment initiation
  • -Comparative effectiveness vs. standard-of-care benchmarks

Electronic Health Record (EHR) Longitudinal Analysis

Extracting clinical endpoints and safety signals directly from primary care and hospital physician notes via NLP.

Patient Cohort

14.2M+12%

Data Latency

24 hrs

NLP Accuracy

96.4%

Key Findings & Signals

  • ▪Identified unlisted mild cardiovascular events in 1.2% of Type 2 Diabetes cohort.
  • ▪Average time to diagnosis reduced by 14 months using early clinical biomarker detection.
  • ▪Confirmed high correlation between early elevated HbA1c and secondary retinal complications.